Intra Cellular Therapies reported $89.19M in Operating Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 158.93M 14.4M
Adamas Pharmaceuticals ADMS:US 31.13M 2.29M
Aptinyx Inc APTX:US $ 19.87M 4.58M
Arena Pharmaceuticals ARNA:US $ 144.39M 12.4M
Biocryst Pharmaceuticals BCRX:US $ 79.54M 9.1M
Biogen BIIB:US $ 1984.9M 304.4M
Bristol Myers Squibb BMY:US $ 9.99B 666M
Cytokinetics CYTK:US $ 57.64M 10.48M
Esperion Therapeutics ESPR:US $ 73.19M 17.61M
Gilead Sciences GILD:US $ 3971M 438M
Gw Pharmaceuticals GWPH:US 173.49M 2.46M
Halozyme Therapeutics HALO:US $ 43.41M 15.84M
Intra Cellular Therapies ITCI:US $ 89.19M 20.09M
JAZZ PHA JAZZ:US $ 821.4M 375.94M
Johnson & Johnson JNJ:US $ 19.49B 2.84B
Marinus Pharmaceuticals MRNS:US $ 25.39M 3.58M
Minerva Neurosciences NERV:US $ 8.96M 1.46M
Nektar Therapeutics NKTR:US $ 138.54M 5.5M
Neurocrine Biosciences NBIX:US $ 226.1M 21M
Novartis NVS:US 9.82B 464M
Prothena PRTA:US 32.12M 147K
Redhill Biopharma RDHL:US 46.39M 7.66M
Supernus Pharmaceuticals SUPN:US $ 107.22M 10.5M
United Therapeutics UTHR:US $ 226.6M 217.3M
Vanda Pharmaceuticals VNDA:US $ 55.53M 3.2M
Zogenix ZGNX:US $ 74.22M 8.73M